MK-0752 Uses, Dosage, Side Effects and more
Mk 0752 is under investigation in clinical trial NCT00572182 (MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer).
| Attribute | Details |
|---|---|
| Trade Name | MK-0752 |
| Generic | MK-0752 |
| Type | |
| Formula | C21H21ClF2O4S |
| Weight | Average: 442.9 Monoisotopic: 442.0817144 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
